News

If climate volatility really is the new normal, I told myself, I need more than bank balances and air-conditioned comfort—I ...
In April 2024, Norgine submitted an application for approval of eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone ...